Germany
Japan
United Kingdom
China
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 3C2-4
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Antibodies
View as table Download
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 3G11-14
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 4A5-19
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 5F4-15
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 5G12-21
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 6F5-23
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 6H8-22
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 8E8-2
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 8F6-6
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 9G5-20
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 12G4-15
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 15C4-8
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 16F12-11
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit Polyclonal Antibody against BRAF (Center)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This B-RAF antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 424-453 amino acids from the Central region of human B-RAF. |
Rabbit Polyclonal Antibody against AKT2 (N-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This AKT2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 93-123 amino acids from the N-terminal region of human AKT2. |
Carrier-free (BSA/glycerol-free) BRAF mouse monoclonal antibody, clone OTI5A9 (formerly 5A9)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
Carrier-free (BSA/glycerol-free) PRKCE mouse monoclonal antibody, clone OTI2A12 (formerly 2A12)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Monkey, Mouse, Rat, Dog |
| Conjugation | Unconjugated |
Carrier-free (BSA/glycerol-free) RPS6KB1 mouse monoclonal antibody, clone OTI1G4 (formerly 1G4)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Active filters
Category
- Antibodies
Reactivities
- Mouse
Applications
- FC
Families
- Protein Kinase
Availabilities
- In Stock
Filter by
Target Symbol
- ERBB2 (50)
- BTK (16)
- PRKCE (13)
- CHEK2 (12)
- BRAF (11)
- CDK2 (11)
- LIMK1 (11)
- MAPK7 (10)
- AKT1 (9)
- NRBP1 (9)
- PRKD2 (9)
- AKT2 (7)
- PLK1 (7)
- PIM2 (6)
- FGFR2 (5)
- FRK (5)
- IGF1R (4)
- PKMYT1 (4)
- PTK7 (4)
- STK39 (4)
- TYRO3 (4)
- DAPK2 (3)
- ERBB3 (3)
- MAP2K4 (3)
- MAPK1 (3)
- RPS6KB1 (3)
- TRIB2 (3)
- AKT3 (2)
- CDK5 (2)
- MAP2K2 (2)
- NEK6 (2)
- NEK9 (2)
- PDGFRB (2)
- PHKG2 (2)
- TLK2 (2)
- UHMK1 (2)
- HSPB8 (1)
- MAPK12 (1)
- MTOR (1)
- PRKAA1 (1)
- PRKG1 (1)
- RET (1)
Antibody Hosts
Isotypes
Clonalities
Conjugates
Knockout (KO) Validation
Pathways
- Pathways in cancer (111)
- Prostate cancer (107)
- ErbB signaling pathway (94)
- Focal adhesion (88)
- Endometrial cancer (84)
- Non-small cell lung cancer (84)
- Pancreatic cancer (82)
- Bladder cancer (69)
- Progesterone-mediated oocyte maturation (59)
- Adherens junction (57)
- Calcium signaling pathway (57)
- Fc epsilon RI signaling pathway (56)
- MAPK signaling pathway (55)
- Fc gamma R-mediated phagocytosis (48)
- Neurotrophin signaling pathway (45)
- Acute myeloid leukemia (44)
- Glioma (41)
- Insulin signaling pathway (41)
- Melanoma (40)
- B cell receptor signaling pathway (39)
- Colorectal cancer (38)
- mTOR signaling pathway (37)
- Cell cycle (34)
- Chronic myeloid leukemia (34)
- Regulation of actin cytoskeleton (34)
- Renal cell carcinoma (34)
- Chemokine signaling pathway (32)
- Tight junction (31)
- Oocyte meiosis (30)
- Vascular smooth muscle contraction (30)
- Small cell lung cancer (29)
- Toll-like receptor signaling pathway (27)
- T cell receptor signaling pathway (24)
- VEGF signaling pathway (24)
- p53 signaling pathway (23)
- Long-term depression (21)
- Adipocytokine signaling pathway (20)
- GnRH signaling pathway (19)
- Apoptosis (18)
- Gap junction (18)
- Jak-STAT signaling pathway (18)
- Thyroid cancer (17)
- Type II diabetes mellitus (17)
- Axon guidance (16)
- Long-term potentiation (16)
- Natural killer cell mediated cytotoxicity (16)
- Primary immunodeficiency (16)
- Endocytosis (13)
- TGF-beta signaling pathway (6)
- Alzheimer's disease (5)
- Melanogenesis (5)
- Prion diseases (5)
- Epithelial cell signaling in Helicobacter pylori infection (4)
- NOD-like receptor signaling pathway (4)
- Dorso-ventral axis formation (3)
- Cytokine-cytokine receptor interaction (2)
- Amyotrophic lateral sclerosis (ALS) (1)
- Hypertrophic cardiomyopathy (HCM) (1)
- Leukocyte transendothelial migration (1)
- Olfactory transduction (1)
- RIG-I-like receptor signaling pathway (1)
- Regulation of autophagy (1)